Milestone Pharmaceuticals

Home » Milestone Pharmaceuticals

IPO

Milestone Pharmaceuticals

We are a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.

Symbol

MIST

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Effective Date
May 9, 2019

Underwriters
JEFFERIES LLC, COWEN AND COMPANY, LLC, PIPER JAFFRAY & CO., OPPENHEIMER & CO. INC.

To view the prospectus for Milestone Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253